August 25, 2015
Novo Nordisk Pharma will launch its human blood plasma coagulation Factor XIII preparation NovoThirteen (recombinant catridecacog) on August 27. The drug will be used in a very small number of patients, but it will be distributed via wholesalers, as with...read more